M
Maria Rendina
Researcher at University of Bari
Publications - 77
Citations - 2041
Maria Rendina is an academic researcher from University of Bari. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 18, co-authored 66 publications receiving 1719 citations. Previous affiliations of Maria Rendina include University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post–liver transplantation patients
Eugene R. Schiff,Ching-Lung Lai,S Hadziyannis,Peter Neuhaus,Norah A. Terrault,Massimo Colombo,Hans L. Tillmann,Didier Samuel,Stefan Zeuzem,Leslie B. Lilly,Maria Rendina,Jean-Pierre Villeneuve,Nicole Lama,C. James,Michael Wulfsohn,H. Namini,Christopher Westland,Shelly Xiong,Gavin S. Choy,Sally Van Doren,John Fry,Carol L. Brosgart +21 more
TL;DR: In conclusion, 48 weeks of adefovir dipivoxil resulted in significant improvements in virologic, biochemical, and clinical parameters in CHB patients pre‐ and post‐LT with lamivudine‐resistant HBV.
Journal ArticleDOI
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Paolo Caraceni,Oliviero Riggio,Paolo Angeli,Carlo Alessandria,Sergio Neri,Francesco Giuseppe Foschi,F. Levantesi,Aldo Airoldi,S. Boccia,Gianluca Svegliati-Baroni,Stefano Fagiuoli,Roberto Giulio Romanelli,Raffaele Cozzolongo,Vito Di Marco,Vincenzo Sangiovanni,Filomena Morisco,Pierluigi Toniutto,Annalisa Tortora,Rosanna De Marco,Mario Angelico,Irene Cacciola,Gianfranco Elia,Alessandro Federico,Sara Massironi,Riccardo Guarisco,Alessandra Galioto,Giorgio Ballardini,Maria Rendina,Silvia Nardelli,Salvatore Piano,Chiara Elia,Loredana Prestianni,Federica Mirici Cappa,Lucia Cesarini,L. Simone,Chiara Pasquale,M. Cavallin,Alida Andrealli,F. Fidone,Matteo Ruggeri,A. Roncadori,Maurizio Baldassarre,Manuel Tufoni,Giacomo Zaccherini,Mauro Bernardi,Marco Domenicali,Ferdinando Giannone,Manuela Merli,Stefania Gioia,Silvano Fasolato,Antonietta Sticca,Daniela Campion,A. Risso,Giorgio Maria Saracco,D. Maiorca,Agostino Rizzotto,Arianna Lanzi,Elga Neri,Anna Visani,Antonio Mastroianni,A Alberti,Chiara Mazzarelli,Marcello Vangeli,Marco Marzioni,Francesca Capretti,Alba Kostandini,G. Magini,M. Colpani,Giacomo Laffi,T Gabbani,Maria Marsico,M. Zappimbulso,Josè Petruzzi,Vincenza Calvaruso,Giovanni Parrella,Nicola Caporaso,Francesco Auriemma,Maria Guarino,Fabio Pugliese,Antonio Gasbarrini,Pietro Leo,Francesco De Leonardis,A. Pecchioli,Piera Rossi,Giovanni Raimondo,Elisa Negri,Marcello Dallio,Carmelina Loguercio,Dario Conte,Natascia Celli,R. Bringiotti,N.M. Castellaneta,Francesco Salerno +92 more
TL;DR: Long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis in this trial.
Journal ArticleDOI
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma.
Luigi Bolondi,Umberto Cillo,Massimo Colombo,Antonio Craxì,Fabio Farinati,Edoardo G. Giannini,Rita Golfieri,Massimo Levrero,Antonio Daniele Pinna,Fabio Piscaglia,Giovanni Raimondo,Franco Trevisani,Raffaele Bruno,Paolo Caraceni,Alessia Ciancio,Barbara Coco,Mirella Fraquelli,Maria Rendina,Giovanni Squadrito,Pierluigi Toniutto +19 more
TL;DR: The Italian Association for the Study of the Liver expert panel recommendations are reported, aiming to provide: (1) homogeneous and efficacious diagnostic and staging work-up, and (2) the best treatment choice tailored to patient status and tumour stage at diagnosis.
Journal ArticleDOI
The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant
Maria Rendina,Antonio Schena,N.M. Castellaneta,F. Losito,Annacinzia Amoruso,Giovanni Stallone,Francesco Paolo Schena,Alfredo Di Leo,Antonio Francavilla +8 more
TL;DR: For the first time in a large cohort of patients that HCV-patients on haemodialysis can be treated successfully with peginterferon alfa-2a (40 kDa) plus ribavirin, it is shown that these patients achieved sustained virological response after 24 weeks of treatment-free follow-up.
Journal ArticleDOI
Early Menopause Is Associated With Lack of Response to Antiviral Therapy in Women With Chronic Hepatitis C
Erica Villa,Aimilia Karampatou,Calogero Cammà,Alfredo Di Leo,Monica Luongo,Anna Ferrari,Salvatore Petta,Luisa Losi,Gloria Taliani,P. Trande,Barbara Lei,Amalia Graziosi,Veronica Bernabucci,Rosina Maria Critelli,Paola Pazienza,Maria Rendina,Alessandro Antonelli,Antonio Francavilla +17 more
TL;DR: Among women with CHC, early menopause was associated with a low likelihood of sustained virologic response (SVR), probably because of inflammatory factors that change atMenopause.